Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation

Health Technol Assess. 2003;7(15):1-136. doi: 10.3310/hta7150.
No abstract available

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Cost-Benefit Analysis
  • Drug Evaluation
  • Emergency Treatment / economics
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / classification
  • Fibrinolytic Agents / economics*
  • Fibrinolytic Agents / therapeutic use*
  • Hospitalization / economics
  • Humans
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / economics
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / economics
  • Recombinant Proteins / therapeutic use
  • Streptokinase / adverse effects
  • Streptokinase / economics
  • Streptokinase / therapeutic use
  • Tenecteplase
  • Thrombolytic Therapy / economics*
  • Time Factors
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / economics
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • reteplase
  • Streptokinase
  • Tissue Plasminogen Activator
  • Tenecteplase